<?xml version="1.0" encoding="UTF-8"?>
<wcm:root xmlns:wcm="http://www.stellent.com/wcm-data/ns/8.0.0">
  <wcm:element name="MainContent">&lt;p&gt;DEPARTMENT OF HEALTH AND HUMAN SERVICES&lt;br /&gt;Food and Drug Administration&lt;br /&gt;[Docket No. FDA&amp;ndash;2009&amp;ndash;N&amp;ndash;0664]&lt;br /&gt;Ear, Nose, and Throat Devices Panel of the Medical Devices Advisory&lt;br /&gt;Committee; Notice of Meeting&amp;nbsp;&lt;/p&gt;&lt;p&gt;AGENCY: Food and Drug Administration, HHS.&lt;br /&gt;ACTION: Notice.&lt;br /&gt;This notice announces a forthcoming meeting of a public advisory committee&lt;br /&gt;of the Food and Drug Administration (FDA). The meeting will be open to the public.&lt;br /&gt;Name of Committee: Ear, Nose, and Throat Devices Panel of the Medical&lt;br /&gt;Devices Advisory Committee.&lt;br /&gt;General Function of the Committee: To provide advice and recommendations&amp;nbsp;&lt;/p&gt;&lt;p&gt;to the agency on FDA&amp;rsquo;s regulatory issues. Date and Time: The meeting will be&lt;br /&gt;held on December 18, 2009, from 8 a.m. to 5 p.m.&lt;br /&gt;Location: Holiday Inn, Ballroom, Two Montgomery Village Ave., Gaithersburg, MD.&lt;br /&gt;Contact Person: James K. Kane, Center for Devices and Radiological Health,&lt;br /&gt;Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD&lt;br /&gt;20993, 301&amp;ndash;796&amp;ndash;6477, or FDA Advisory Committee Information Line, 1&amp;ndash;800&amp;ndash;&lt;br /&gt;741&amp;ndash;8138 (301&amp;ndash;443&amp;ndash;0572 in the Washington, DC area), code&lt;br /&gt;3014512522. Please call the Information Line for up-to-date information on this&lt;br /&gt;meeting. A notice in the Federal Register about last minute modifications&lt;br /&gt;that impact a previously announced advisory committee meeting cannot&lt;br /&gt;always be published quickly enough to provide timely notice. Therefore, you&lt;br /&gt;should always check the agency&amp;rsquo;s Web site and call the appropriate advisory&lt;br /&gt;committee hot line/phone line to learn about possible modifications before&lt;br /&gt;coming to the meeting.&lt;/p&gt;&lt;p&gt;&lt;br /&gt;Agenda: On December 18, 2009, the committee will discuss, make&lt;br /&gt;recommendations, and vote on a premarket approval application,&lt;br /&gt;sponsored by Envoy Medical Corporation, for the Esteem Totally&lt;br /&gt;Implantable Hearing System. The ESTEEM is a totally implantable hearing&lt;br /&gt;device that is implanted in the middle ear to help hearing in patients suffering&lt;br /&gt;from mild to severe hearing loss that is sensorineural in origin. The Esteem&lt;br /&gt;System consists of three implantable components (Sound Processor, Sensor,&lt;br /&gt;and Driver), two external programmers (Esteem Programmer and Personal&lt;br /&gt;Programmer), an external Intraoperative System Analyzer (ISA) and accessories.&lt;br /&gt;The intended use of the ESTEEM is to alleviate hearing loss in adults by&lt;br /&gt;replicating the ossicular chain and providing additional gain.&lt;br /&gt;FDA intends to make background material available to the public no later&lt;br /&gt;than 2 business days before the meeting. If FDA is unable to post the background&lt;br /&gt;material on its Web site prior to the meeting, the background material will&lt;br /&gt;be made publicly available at the location of the advisory committee&lt;br /&gt;meeting, and the background material will be posted on FDA&amp;rsquo;s Web site after&lt;br /&gt;the meeting. Background material is available at http://www.fda.gov/&lt;br /&gt;AdvisoryCommittees/Calendar/default.htm. Scroll down to the&lt;br /&gt;appropriate advisory committee link.&lt;/p&gt;&lt;p&gt;&lt;br /&gt;Procedure: Interested persons may present data, information, or views,&lt;br /&gt;orally or in writing, on issues pending before the committee. Written&lt;br /&gt;submissions may be made to the contact person on or before December 8, 2009.&lt;br /&gt;Oral presentations from the public will be scheduled between approximately 1&lt;br /&gt;p.m. and 2 p.m. Those desiring to make formal oral presentations should notify&lt;br /&gt;the contact person and submit a brief statement of the general nature of the&lt;br /&gt;evidence or arguments they wish to present, the names and addresses of&lt;br /&gt;proposed participants, and an indication of the approximate time&lt;br /&gt;requested to make their presentation on or before November 30, 2009. Time&lt;br /&gt;allotted for each presentation may be limited. If the number of registrants&lt;br /&gt;requesting to speak is greater than can be reasonably accommodated during the&lt;br /&gt;scheduled open public hearing session, FDA may conduct a lottery to determine&lt;br /&gt;the speakers for the scheduled open public hearing session. The contact&lt;br /&gt;person will notify interested persons regarding their request to speak by&lt;br /&gt;December 1, 2009.&lt;/p&gt;&lt;p&gt;&lt;br /&gt;Persons attending FDA&amp;rsquo;s advisory committee meetings are advised that the&lt;br /&gt;agency is not responsible for providing access to electrical outlets.&lt;br /&gt;FDA welcomes the attendance of the public at its advisory committee&lt;br /&gt;meetings and will make every effort to accommodate persons with physical&lt;br /&gt;disabilities or special needs. If you require special accommodations due to&lt;br /&gt;a disability, please contact AnnMarie Williams, 301&amp;ndash;796&amp;ndash;5966 or&lt;br /&gt;annmarie.williams@fda.hhs.gov by December 4, 2009.&lt;br /&gt;FDA is committed to the orderly conduct of its advisory committee&lt;br /&gt;meetings. Please visit our Web site at http://www.fda.gov/Advisory&lt;br /&gt;Committees/AboutAdvisoryCommittees/ucm111462.htm for procedures on&lt;br /&gt;public conduct during advisory committee meetings. Notice of this meeting is given under&lt;br /&gt;the Federal Advisory Committee Act (5U.S.C. app. 2).&lt;br /&gt;Dated: October 27, 2009.&lt;br /&gt;David Horowitz,&lt;br /&gt;Assistant Commissioner for Policy.&lt;br /&gt;[FR Doc. E9&amp;ndash;26260 Filed 10&amp;ndash;30&amp;ndash;09; 8:45 am]&lt;br /&gt;BILLING CODE 4160&amp;ndash;01&amp;ndash;S&lt;/p&gt;</wcm:element>
<wcm:element name="MainList1"></wcm:element>
  <wcm:element name="MainList2"></wcm:element>
  <wcm:element name="MainList3"></wcm:element>
</wcm:root>
